netFormulary
 Report : A-Z NHS England items in Formulary 24/01/2021 23:57:35
[Back]
 
Section Status NHS England Name
08.01.05 Formulary MHS England Abemaciclib Verzenios®
13.05.03 Restricted Use MHS England Adalimumab Humira®
08.01.05 Formulary MHS England Alectinib Alecensa®
08.01.05 Formulary MHS England Arsenic Trioxide Trisenox®
08.02.03 Formulary MHS England Atezolizumab Tecentriq®
08.02.03 Formulary MHS England Avelumab Bavencio®
08.02.04 Formulary MHS England Axicabtagene ciloleucel Yescarta®
08.01.05 Formulary MHS England Axitinib Inlyta®
03.04.02 Formulary MHS England Benralizumab Fasenra®
08.01.05 Formulary MHS England Bortezomib Velcade®
08.01.05 Formulary MHS England Bosutinib Bosulif®
08.01.05 Formulary MHS England Brentuximab vedotin Adcetris®
08.01.05 Formulary MHS England Brigatinib Alunbrig®
08.01.05 Formulary MHS England Cabazitaxel Jevtana®
08.01.05 Formulary MHS England Cabozantinib  Cabometyx®
04.08.01 Formulary MHS England Cannabidiol Epidyolex®
08.01.05 Formulary MHS England Carfilzomib Kyprolis ®
08.01.05 Formulary MHS England Cemiplimab Libtayo®
08.01.05 Formulary MHS England Ceritinib Zykadia®
08.01.03 Formulary MHS England Cladribine Mavenclad®
08.01.03 Formulary MHS England Cytarabine-Daunorubicin liposomal Vyxeos®
08.01.05 Formulary MHS England Dabrafenib mesilate Tafinlar®
08.01.05 Formulary MHS England Dacomitinib Vizimpro®
08.01.05 Formulary MHS England Daratumumab  Darzalex®
08.02.04 Formulary MHS England Dimethyl fumarate Tecfidera®
08.02.03 Formulary MHS England Dinutuximab Qarziba®
03.07 Formulary MHS England Dornase Alfa Pulmozyme®
08.01.05 Formulary MHS England Durvalumab Imfinzi®
08.01.05 Formulary MHS England Encorafenib  Braftovi®
08.02.03 Formulary MHS England Gemtuzumab ozogamicin Mylotarg®
05.03.03.02 Restricted Use MHS England Glecaprevir - pibrentasvir Maviret®
08.01.05 Formulary MHS England Ibrutinib Imbruvica ®
08.02.03 Formulary MHS England Inotuzumab ozogamicin Besponsa®
08.01.05 Formulary MHS England Ipilimumab Yervoy®
03.04.03 Formulary MHS England Lanadelumab Takhzyro®
08.02.04 Formulary MHS England Larotrectinib 
08.02.04 Formulary MHS England Lenalidomide Revlimid®
08.01.05 Formulary MHS England Lenvatinib Kisplyx®
05.03.02.02 Formulary MHS England Letermovir Prevymis®
08.01.05 Formulary MHS England Lorlatinib 
03.07 Formulary MHS England Lumacaftor with ivacaftor Orkambi®
03.07 Formulary MHS England Mannitol Dry Powder Bronchitol ®
02.03.02 Formulary MHS England Mexiletine  
08.01.05 Formulary MHS England Midostaurin Rydapt®
08.03.04.01 Formulary MHS England Neratinib Nerlynx®
08.01.05 Formulary MHS England Niraparib Zejula®
08.02.03 Formulary MHS England Nivolumab Opdivo®
10.02 Formulary MHS England Nusinersen® Spinraza
01.09.01 Restricted Use MHS England Obeticholic acid 
08.02.03 Formulary MHS England Obinutuzumab  Gazyvaro®
08.02.03 Formulary MHS England Ocrelizumab  Ocrevus®
08.01.05 Formulary MHS England Olaparib Lynparza®
03.04.02 Restricted Use MHS England Omalizumab 
08.01.05 Formulary MHS England Osimertinib  Tagrisso ®
08.01.05 Formulary MHS England Paclitaxel - Albumin Bound Formulation Abraxane®
08.01.05 Formulary MHS England Palbociclib Ibrance®
08.02.04 Formulary MHS England Peginterferon Beta-1a Plegridy®
08.02.03 Formulary MHS England Pembrolizumab Keytruda®
08.01.05 Formulary MHS England Pertuzumab Perjeta®
03.11 Restricted Use MHS England Pirfenidone 
08.01.02 Formulary MHS England Pixantrone Pixuvri®
08.02.03 Formulary MHS England Polatuzumab vedotin Polivy®
08.02.04 Formulary MHS England Pomalidomide Imnovid®
08.01.05 Formulary MHS England Regorafenib Stivarga®
08.01.05 Formulary MHS England Ribociclib Kisqali®
08.02.04 Formulary MHS England Rucaparib Rubraca®
08.01.05 Formulary MHS England Ruxolitinib Jakavi®
09.05.02.02 Restricted Use MHS England Sevelamer  
05.03.03.02 Restricted Use MHS England Sofosbuvir-velpatasvir-voxilaprevir 
08.01.05 Formulary MHS England Talimogene laherparepvec Imlygic®
08.02.04 Formulary MHS England Teriflunomide Aubagio®
08.02.04 Formulary MHS England Thalidomide Celgene®
08.01.05 Formulary MHS England Tisagenlecleucel Kymriah®
08.01.05 Formulary MHS England Tivozanib Fotivda®
06.05.02 Restricted Use MHS England Tolvaptan Jinarc®
08.01.05 Formulary MHS England Trametinib Mekinist®
08.01.05 Formulary MHS England Trastuzumab 
08.01.05 Formulary MHS England Trastuzumab emtansine 
08.01.01 Formulary MHS England Treosulfan Trecondi®
08.01.03 Formulary MHS England Trifluridine tipiracil Lonsurf®
08.01.05 Formulary MHS England Venetoclax Venclyxto®
South Staffordshire Joint Formulary